Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...
A change of tone from the US authorities has introduced new uncertainties. Under health secretary and outspoken vaccine ...
At J.P. Morgan 2026, Pfizer CEO Albert Bourla positioned the company as a post-COVID operator focused on disciplined ...
18don MSN
Where will Pfizer be in 5 years?
Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the big leagues.
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...
The U.S. Department of Health and Human Services said it will cut $500 million in funding for 22 mRNA-based vaccine projects targeting COVID-19, flu, and H5N1, halting initiatives led by companies ...
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr. that directly affects ...
(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback